Vertex Pharmaceuticals, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
REGNRegeneron Pharmaceuticals, Inc. 0.36%574.442.7%$667.24m
AMGNAmgen, Inc. -0.83%227.061.3%$582.28m
ILMNIllumina, Inc. 2.50%325.813.5%$569.38m
GILDGilead Sciences, Inc. -0.04%60.191.0%$501.18m
MRNAModerna, Inc. 3.95%71.070.0%$490.36m
VRTXVertex Pharmaceuticals, Inc. -0.21%210.941.9%$487.34m
ARRYArray BioPharma Inc. 1.25%39.8314.2%$484.32m
IMMUImmunomedics, Inc. 0.05%87.8711.0%$373.48m
NVAXNovavax, Inc. 2.86%93.7796.5%$311.46m
ALXNAlexion Pharmaceuticals, Inc. 1.68%120.172.0%$285.11m
BIIBBiogen, Inc. -1.69%264.361.6%$260.12m
EXASEXACT Sciences Corp. 7.17%106.7520.7%$235.28m
BNTXBioNTech SE -1.79%86.150.0%$210.82m
SRNESorrento Therapeutics, Inc. 5.29%8.271.4%$191.03m
SGENSeagen Inc. 1.38%200.456.0%$164.62m

Company Profile

Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. It focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.